Stock ALZN ALZAMEND NEURO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Alzamend Neuro, Inc.

Equities

ALZN

US02262M4078

Delayed Nasdaq
Other stock markets
 13:30:58 2024-05-01 EDT 		5-day change 1st Jan Change
0.7201 USD +1.28% Intraday chart for Alzamend Neuro, Inc. +1.54% -19.09%
03-25 Alzamend Neuro, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024 CI
01-31 Alzamend Neuro, Inc. announced that it expects to receive $6 million in funding from Ault Lending, LLC CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Maxim Initiates Alzamend Neuro at Buy With $1.50 Price Target
MT
Ascendiant Capital Adjusts Price Target on Alzamend Neuro to $8.25 From $8, Maintains Buy Rating
MT
ALZAMEND NEURO : Ascendiant Capital Initiates Alzamend Neuro at Buy Rating With $8 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ALZN Stock
  4. News Alzamend Neuro, Inc.
  5. Analyst Reco.